NK cells can also kill tumor cells by antibody-dependent cellular cytotoxicity (ADCC), mediated by the CD16 receptor (FcγRIIIa), which recognizes the fragment crystallizable (Fc) portion of IgG bound to the target cell [24]. Here, FCGR3A is linked to neoplasm.